New Delhi, Nov. 7 -- US President Donald Trump's move to cut pharmaceutical drug prices in America can potentially turn out to be a $35 billion additional cost to the federal government over the years.

On 6 November 2025, President Trump announced that the federal government has decided to reduce the prices for prescription drugs in the US economy, while also directing manufacturers like Eli Lilly and Novo Nordisk to cut their drug costs.

According to the official announcement, the federal government's agreement will cut the prices of those drugs with the highest annual expenditures in the United States in efforts to assist Americans who are struggling to pay for medicines for diabetes, heart disease, obesity, and other ailments.

Ozemp...